Fidelity Investments’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$95.9M Buy
8,054,691
+423,256
+6% +$4.33M 0.01% 1200
2025
Q4
$76M Sell
7,631,435
-1,362,002
-15% -$13M ﹤0.01% 1284
2025
Q3
$80.5M Buy
8,993,437
+13,764
+0.2% +$127K ﹤0.01% 1270
2025
Q2
$84.7M Buy
8,979,673
+2,267,333
+34% +$20M ﹤0.01% 1186
2025
Q1
$72.8M Sell
6,712,340
-950,306
-12% -$9.56M ﹤0.01% 1215
2024
Q4
$72.9M Buy
7,662,646
+312,097
+4% +$3.16M ﹤0.01% 1237
2024
Q3
$82.5M Buy
7,350,549
+624,645
+9% +$6.64M 0.01% 1180
2024
Q2
$67.3M Buy
6,725,904
+786,117
+13% +$7.99M ﹤0.01% 1193
2024
Q1
$68.4M Sell
5,939,787
-2,795,518
-32% -$23.7M ﹤0.01% 1203
2023
Q4
$63.7M Sell
8,735,305
-97,608
-1% -$770K ﹤0.01% 1201
2023
Q3
$80.4M Buy
8,832,913
+17,754
+0.2% +$213K 0.01% 1060
2023
Q2
$107M Sell
8,815,159
-973,386
-10% -$10.8M 0.01% 961
2023
Q1
$122M Buy
9,788,545
+313,834
+3% +$5.77M 0.01% 918
2022
Q4
$182M Buy
9,474,711
+913,470
+11% +$19.3M 0.02% 721
2022
Q3
$161M Buy
8,561,241
+1,063,812
+14% +$21.9M 0.02% 757
2022
Q2
$135M Buy
7,497,429
+1,887,639
+34% +$30.6M 0.01% 842
2022
Q1
$89.9M Buy
5,609,790
+5,358,591
+2,133% +$96.4M 0.01% 1111
2021
Q4
$6.14M Buy
251,199
+250,910
+86,820% +$5.89M ﹤0.01% 2295
2021
Q3
$6K Sell
289
-171,675
-100% -$4.15M ﹤0.01% 3722
2021
Q2
$4.71M Sell
171,964
-369,883
-68% -$10.5M ﹤0.01% 2345
2021
Q1
$19.9M Sell
541,847
-203,511
-27% -$7.19M ﹤0.01% 1807
2020
Q4
$28M Sell
745,358
-56,613
-7% -$1.75M ﹤0.01% 1564
2020
Q3
$17.5M Buy
801,971
+215,841
+37% +$4.53M ﹤0.01% 1615
2020
Q2
$9.44M Buy
586,130
+186,244
+47% +$3.11M ﹤0.01% 1841
2020
Q1
$6.4M Buy
399,886
+6,886
+2% +$97.3K ﹤0.01% 1846
2019
Q4
$4.32M Hold
393,000
﹤0.01% 2086
2019
Q3
$4.01M Buy
+393,000
New +$4.01M ﹤0.01% 2111

Other funds holding AHCO

Fidelity Investments's AHCO Position: Q1 2026 in Review

Fidelity Investments increased its AdaptHealth (AHCO) stake by 5.5% in Q1 2026, buying an estimated $4.33M and bringing the position to 8,054,691 shares worth $95.9M. The position accounts for 0.01% of the portfolio, ranked #1200.

Fidelity Investments first reported a position in AHCO in Q3 2019 and has held it in 27 quarters since. The position peaked at $182M in Q4 2022. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Fidelity Investments held 8,054,691 shares of AdaptHealth worth $95.9M as of Q1 2026.
  • Fidelity Investments bought 423,256 AdaptHealth shares in Q1 2026, an estimated $4.33M.
  • AdaptHealth made up 0.01% of Fidelity Investments's portfolio in Q1 2026, its #1200 holding.
  • Fidelity Investments first reported a position in AdaptHealth in Q3 2019 and has held it in 27 quarters since.
  • Fidelity Investments's AdaptHealth position peaked at $182M in Q4 2022.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.